# FDA recall Z-0606-2018

> **Gibson Laboratories LLC** · Class II · device recall initiated 2017-01-20.

## Product

Blastomyces dermatitidis Antiserum 1 mL vial GIBSON BIOSCIENCE.  Catalog 200265    Intended for identification of the systemic fungal pathogens.

## Reason for recall

The firm information that the product was reporting false positive results

## Distribution

Distributed to the states of AL, AZ & MS.

## Key facts

- **Recall number:** Z-0606-2018
- **Recalling firm:** Gibson Laboratories LLC
- **Classification:** Class II
- **Product type:** device
- **Status:** Terminated
- **Initiation date:** 2017-01-20
- **Report date:** 2018-02-21
- **Termination date:** 2018-02-20

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Lexington, KY, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-0606-2018

## Citation

> AI Analytics. FDA recall Z-0606-2018. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/Z-0606-2018. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*